Edition:
United Kingdom

Akcea Therapeutics Inc (AKCA.OQ)

AKCA.OQ on NASDAQ Stock Exchange Global Select Market

27.98USD
21 Sep 2018
Change (% chg)

$-0.94 (-3.25%)
Prev Close
$28.92
Open
$29.07
Day's High
$29.07
Day's Low
$27.37
Volume
183,144
Avg. Vol
81,153
52-wk High
$40.60
52-wk Low
$15.20

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.79 December 25 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 2 1 1 1
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.20 2.25 2.25 2.25

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 5 19.82 37.40 10.00 37.40
Quarter Ending Dec-18 5 42.99 90.70 18.90 37.40
Year Ending Dec-18 5 98.34 164.00 71.40 76.10
Year Ending Dec-19 5 366.94 874.00 100.90 299.81
Earnings (per share)
Quarter Ending Sep-18 5 -0.79 -0.56 -0.89 --
Quarter Ending Dec-18 5 -0.58 0.03 -0.94 --
Year Ending Dec-18 5 -2.57 -1.70 -3.10 -1.01
Year Ending Dec-19 5 -0.62 5.88 -3.33 0.84

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-18 12.56 18.32 5.77 45.93
Quarter Ending Mar-18 12.12 17.11 4.98 41.11
Quarter Ending Dec-17 11.92 18.03 6.11 51.28
Quarter Ending Sep-17 11.91 13.45 1.54 12.95

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 19.82 22.27 23.14 23.54 37.40
Quarter Ending Dec-18 42.99 46.03 49.47 51.81 37.40
Year Ending Dec-18 98.34 103.86 106.72 105.08 76.10
Year Ending Dec-19 366.94 415.18 442.86 443.76 299.81

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 1 1
Quarter Ending Dec-18 0 0 0 2
Year Ending Dec-18 0 0 1 1
Year Ending Dec-19 0 0 0 2
Earnings